BioCentury
ARTICLE | Financial News

Myriad Genetics completes debt financing

September 12, 2016 7:00 AM UTC

Myriad Genetics Inc. (NASDAQ:MYGN), Salt Lake City, Utah Business: Diagnostic Date completed: 2016-09-01 Type: Debt financing Raised: $200 million Shares outstanding prior: 69.1 million Investor: JPMo...